Brief: Bellicum Pharmaceuticals files prospectus relating to disposition of up to about 5 million shares
June 28 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O
* Bellicum Pharmaceuticals files prospectus relating to
disposition of up to about 5 million shares of co's common stock
held by the selling stockholders
* Bellicum Pharmaceuticals says it is not selling any shares
of common stock and will not receive any of the proceeds from
sale of shares by selling stockholders
Source text for Eikon: ID:nEOL4dv8G6
Further company coverage: BLCM.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview